Guest guest Posted October 18, 2005 Report Share Posted October 18, 2005 E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER Vienna, Virginia http://www.nvic.org * * * * * * * * * * * * * * * * * * * * * * * UNITED WAY/COMBINED FEDERAL CAMPAIGN #8122 * * * * * * * * * * * * * * * * * * * * * * * " Protecting the health and informed consent rights of children since 1982. " ============================================================================ ============== BL Fisher Note: Drug companies, with the assistance of medical organizations and public health officials, have been lobbying Congress for more tha 40 years for an " exclusive remedy " federal compensation program which would completely remove all product liability for injuries and deaths caused by mandated vaccines. Parents, who worked on the National Childhood Vaccine Injury Act of 1986, were able to protect the civil right to access the tort system for vaccine injuries and deaths if a child was turned down for federal compensation or offered too little, as well as in cases where criminal negligence or fraud on the part of the drug company could be proved in court. That right to go to court has been threatened by pharmaceutical lobbyists joining with physician organizations and federal health officials intent upon strengthening the forced mass vaccination system in America. With government, industry and medical organizations like the American Academy of Pediatrics advocating for the removal of informed consent protections from mandatory vaccination laws, it is very dangerous to combine the banning of lawsuits for vaccine injuries and deaths with draconian forced vaccination policies. This amounts to a totalitarian approach to health policy which leaves profit-making corporations and doctor officials inside and outside of government totally unaccountable for their actions when citizens follow their orders and then are harmed by vaccines, whether that harm occurs in an emergency or non-emergency situation. The call by President Bush to use the military to enforce quarantines in the case of a flu pandemic is the wake-up call. Forced quarantine is the first step. Forced vaccination is the second step as soliders with syringes set up camp in the small towns and big cities of America. http://www.thehill.com/thehill/export/TheHill/Business/101205_vaccine.html The Hill Immunity sought as avian flu shadow approaches By Jim Snyder Rising worry about a bird-flu pandemic is reviving drug-company hopes for legal protections to produce vaccines. The debate once centered on preparations for a terrorist attack that released deadly strains of anthrax or smallpox. But the administration and lawmakers are now rushing to prepare for a global flu outbreak that medical experts say is almost sure to happen. The Senate already has approved an amendment offered by Sen. Tom Harkin (D-Iowa) that added $3.9 billion to the military spending measure to prepare for the flu. The money will be used to stockpile medications to combat the flu. Lobbyists from pharmaceutical companies say a critical component of any effort is immunity from lawsuits if a vaccination causes harm. Without new legal safeguards, pharmaceutical companies are unlikely to produce vaccines, a business that offers little reward but a lot of risk, lobbyists say. " Vaccines are not Viagra, " said Clerici of McKenna, Long and Aldridge, which represents Sanofi Pasteur, a French company that has a vaccine-manufacturing plant in Pennsylvania, and other pharmaceutical companies. " You aren't going to make a huge amount of money making vaccines. " This month, the Department of Health and Human Services awarded Sanofi a $97 million contract to develop a new type of flu vaccine. But a deterrent for wider participation among the industry is the potential liability, which Clerici said is huge because the number of people who would use a vaccine in a global outbreak likely will reach in the hundreds of millions. The debate over liability protection pits two rival lobbying powers against one another once again: drug companies and trial lawyers. The Association of Trial Lawyers of America (ATLA) opposes " efforts by some in Congress and their friends in the pharmaceutical industry to use the threat of outbreak as means to provide big giveaways to special interests, " said ATLA spokeswoman Mather. The association instead favors reforming the Vaccine Injury Compensation Program, which set up a federal, court-like process through which alleged victims of vaccination could seek financial compensation. Created in 1986, the program has settled 1,200 vaccine claims worth $1.2 billion as of 2004. But it has come under criticism for being too slow in giving victims redress. Recent battles over liability protection were fought as Congress debated Project Bioshield, an effort by the White House to develop " medical countermeasures " to biological and chemical terrorist attacks. After liability protection for makers of thimerosal, a vaccine component some say may be linked to a rising incidence of autism, was attached to the 2002 homeland-security bill in the dead of night - it was later removed - Congress had little appetite to attach liability protections to Bioshield when it passed the act in 2004. But as the so-called bird flu spreads around the globe, though it has killed relatively few humans, Congress and the administration have taken new interest in vaccine development. Last week's news that the 1918 pandemic that killed at least 50 million people was a mutated avian strain transferable by human-to-human contact has provided additional momentum. Several lawmakers have introduced bills or are drafting them to improve the system for producing and distributing vaccines - both for flu outbreaks and biological attacks. Sens. Hillary Rodham Clinton (D-N.Y.) and Pat (R-Kan.), for example, last week introduced the Influenza Vaccine Security Act. The bill's provisions include shifting the liability from pharmaceutical companies to the federal government for " personal injury or death resulting from the manufacture, administration or use of qualified pandemic influenza technologies. " Mather said ATLA was still reviewing the bill. Chiron, the flu-vaccine maker, is listed as a supporter of the bill. Sen. Burr (R-N.C.), who is chairman of the Senate Health Committee's Bioterrorism and Public Health Preparedness Subcommittee, has said he will introduce a broad measure next week to prepare for a bioterrorism or flu outbreak. Doug Heye, a spokesman for Burr, said the bill, which is still being drafted, is likely to borrow from a bill already introduced by Sen. Judd Gregg (R-N.H.) that provides drug companies with liability protection. " We need to provide incentives to companies to bring drugs and vaccines to the marketplace, " Heye said. Participation in Bioshield has so far been disappointing. Congress made available $5.6 billion to drug companies to develop new drugs or vaccines. But Clerici said only three contracts, worth a total of around $1 billion, have been awarded. Drug companies have " not participated at a level anticipated after Bioshield, " Heye acknowledged. But Mather noted news reports suggesting more companies are interested in producing vaccines, even without liability protection. Executives from pharmaceutical giants like GlaxoKline and Wyeth have announced investments in vaccine production facilities, Maher said. ============================================= News@... is a free service of the National Vaccine Information Center and is supported through membership donations. Learn more about vaccines, diseases and how to protect your informed consent rights http://www.nvic.org Become a member and support NVIC's work https://www.nvic.org/making%20cash%20donations.htm To sign up for a free e-mail subscription http://www.nvic.org/emaillist.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.